PRPM Stock | News | Quote | Stock Forum | Sunday, November 10,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$PRPM ProTek Capital, Inc. PRPM Company Overview 

ProTek Capital, Inc. PRPM Current Price and Quotes
Last Price 0.0002
Previous Close 0.0003 Open 0.0002
Daily Range 0.0003 - 0.0001 52wk Range 0.0008 - 0.0001
Volume 66,474,475 Dividend N/A
Average Vol (3m) 74,491,028 Yield N/A

PRPM Stock Message Board http://investorshangout.com/search?q=PRPM&...mp;yt1=Go!

Last Updated: Sunday, November 10, 2013 01:40:11 AM

ProTek Capital, Inc. PRPM

Company Verified Profile
Company Information

1712 Pioneer Ave # 201
Cheyenne, WY 82001

Website: http://www.protekcapital.com
Email: ev24903@gmail.com

ProTek Capital, Inc. PRPM
ProTek is in the process of expanding & updating its investment focus to concentrate on businesses within developing economies that are anticipated to have high growth opportunities. Specifically, ProTek will broaden its investment focus to include developing high growth business opportunities located within the Caribbean, Gulf of Mexico and South America. ProTek is expanding its investment scope beyond software companies to include any early stage business investments within promising market s...



ProTek Capital, Inc. PRPM
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o Jun 24, 2009
Audited Financials Unaudited
Latest Report Jul 31, 2013 Quarterly Report
CIK 0001421100
Fiscal Year End 1/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 6799 - Investors, misc
Incorporated In: WY, USA
Year of Inc. 2005
Employees 3 a/o Oct 27, 2010
Company Officers/Contacts

Edward Vakser CEO
James S. Tassan Acting CFO
Company Directors

Not Available
Company Notes

Formerly=Propalms, Inc. until 10-2010
Formerly=Propalms USA, Inc. until 6-07
Formerly=Jenna Lane, Inc. until 3-07
Note=6-30-00 involuntary petition under Chapter 7 of the Bankruptcy Code filed against the company in the U.S. Bankruptcy Court for the Southern District of New York. 7-6-00 company converted case to Chapter XI of the Bankruptcy Code. 11-18-01 Court dismissed the Chapter XI Case
Service Providers

Auditor/Accountant
Craig Workinger, CPA
629 Camino de Los Mares
San Clemente, CA, 92673
United States

Legal Counsel
Jonathan D. Leinwand, P.A.
200 South Andrews Ave
Ft Lauderdale, FL, 33301
United States

Investor Relations Firm
Not Available

ProTek Capital, Inc. PRPM
PRPM Security Details

Share Structure

Market Value1 $605,444 a/o Nov 08, 2013
Shares Outstanding 3,027,218,472 a/o Jul 31, 2013
Float 2,461,467,187 a/o Jan 31, 2013
Authorized Shares 4,000,000,000 a/o Jul 31, 2013
Par Value  0.0001
Shareholders

Shareholders of Record 64 a/o Jan 31, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) *  Nov 03, 2010 Dec 09, 2010
Dividend (0.00) *  Jul 16, 2010 Aug 16, 2010
Short Selling Data

Short Interest 0 (-100%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Pacific Stock Transfer Co.

ProTek Capital, Inc. PRPM Financials
PRPM


ProTek Capital, Inc. PRPM Recent News

Aug 29, 2013 ProTek Capital and American Performance Technologies Seek Growth Capital to Support Continued Sales Growth, Market Penetration, and Product Development Strategies.
Aug 15, 2013 ProTek Capital Announces LOI to Acquire MotoVox(R) Small Engine and Power Sport Products Manufacturer With Approximately $12 Million in Annual Revenue


PRPM ProTek Capital, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PRPM&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PRPM/quote
Stock Chart http://www.otcmarkets.com/stock/PRPM/chart
Company Info http://www.otcmarkets.com/stock/PRPM/company-info
Recent News http://www.otcmarkets.com/stock/PRPM/news
Financials http://www.otcmarkets.com/stock/PRPM/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PRPM/filings
Short Sales http://www.otcmarkets.com/stock/PRPM/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PRPM/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PRPM/research
Summary http://finance.yahoo.com/q?s=PRPM
Historical Prices http://finance.yahoo.com/q/hp?s=PRPM+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PRPM
Basic Chart http://finance.yahoo.com/q/bc?s=PRPM+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PRPM+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PRPM+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PRPM+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PRPM+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PRPM+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PRPM+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PRPM+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PRPM+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PRPM+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PRPM
Balance Sheet http://finance.yahoo.com/q/bs?s=PRPM
Cash Flow http://finance.yahoo.com/q/cf?s=PRPM+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PRPM
Market Watch http://www.marketwatch.com/investing/stock/PRPM
Bloomberg http://www.bloomberg.com/quote/PRPM:US
Morningstar http://quotes.morningstar.com/stock/s?t=PRPM
Bussinessweek http://investing.businessweek.com/research/st...icker=PRPM
Barchart http://www.barchart.com/quotes/stocks/PRPM
OTC Short Report http://otcshortreport.com/index.php?index=PRPM
Investopedia http://www.investopedia.com/markets/stocks/PRPM/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading